217 related articles for article (PubMed ID: 12595566)
1. Transcriptional activation by AP-2alpha is modulated by the oncogene DEK.
Campillos M; García MA; Valdivieso F; Vázquez J
Nucleic Acids Res; 2003 Mar; 31(5):1571-5. PubMed ID: 12595566
[TBL] [Abstract][Full Text] [Related]
2. Regulation of DEK expression by AP-2α and methylation level of DEK promoter in hepatocellular carcinoma.
Qiao MX; Li C; Zhang AQ; Hou LL; Yang J; Hu HG
Oncol Rep; 2016 Oct; 36(4):2382-90. PubMed ID: 27499261
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of the interacting domains of the positive coactivator PC4 with the transcription factor AP-2alpha.
Zhong L; Wang Y; Kannan P; Tainsky MA
Gene; 2003 Nov; 320():155-64. PubMed ID: 14597399
[TBL] [Abstract][Full Text] [Related]
4. Dual regulation of AP-2alpha transcriptional activation by poly(ADP-ribose) polymerase-1.
Li M; Naidu P; Yu Y; Berger NA; Kannan P
Biochem J; 2004 Aug; 382(Pt 1):323-9. PubMed ID: 15170387
[TBL] [Abstract][Full Text] [Related]
5. High-affinity interaction of poly(ADP-ribose) and the human DEK oncoprotein depends upon chain length.
Fahrer J; Popp O; Malanga M; Beneke S; Markovitz DM; Ferrando-May E; Bürkle A; Kappes F
Biochemistry; 2010 Aug; 49(33):7119-30. PubMed ID: 20669926
[TBL] [Abstract][Full Text] [Related]
6. DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer.
Fu GK; Grosveld G; Markovitz DM
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1811-5. PubMed ID: 9050861
[TBL] [Abstract][Full Text] [Related]
7. YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter.
Sitwala KV; Adams K; Markovitz DM
Oncogene; 2002 Dec; 21(57):8862-70. PubMed ID: 12483538
[TBL] [Abstract][Full Text] [Related]
8. Identification of an enhancer of the human activating protein-2alpha gene that contains a critical Ets1 binding site.
Cheng YH; Handwerger S
J Clin Endocrinol Metab; 2003 Jul; 88(7):3305-11. PubMed ID: 12843180
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of transcription factor AP-2 stimulates the PA promoter of the human uracil-DNA glycosylase (UNG) gene through a mechanism involving derepression.
Aas PA; Peña-Diaz J; Liabakk NB; Krokan HE; Skorpen F
DNA Repair (Amst); 2009 Jul; 8(7):822-33. PubMed ID: 19411194
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of the RelA/p65 transactivation function by the product of the DEK proto-oncogene.
Sammons M; Wan SS; Vogel NL; Mientjes EJ; Grosveld G; Ashburner BP
J Biol Chem; 2006 Sep; 281(37):26802-12. PubMed ID: 16829531
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor AP-2 activity is modulated by protein kinase A-mediated phosphorylation.
García MA; Campillos M; Marina A; Valdivieso F; Vázquez J
FEBS Lett; 1999 Feb; 444(1):27-31. PubMed ID: 10037142
[TBL] [Abstract][Full Text] [Related]
12. Identification of amino acid residues of transcription factor AP-2 involved in DNA binding.
García MA; Campillos M; Ogueta S; Valdivieso F; Vázquez J
J Mol Biol; 2000 Aug; 301(4):807-16. PubMed ID: 10966787
[TBL] [Abstract][Full Text] [Related]
13. AP-2alpha modulates human corticotropin-releasing hormone gene expression in the placenta by direct protein-protein interaction.
Cheng YH; Handwerger S
Mol Cell Endocrinol; 2002 Jun; 191(2):127-36. PubMed ID: 12062896
[TBL] [Abstract][Full Text] [Related]
14. Novel activator protein-2alpha splice-variants function as transactivators of the ovine placental lactogen gene.
Limesand SW; Anthony RV
Eur J Biochem; 2001 Apr; 268(8):2390-401. PubMed ID: 11298758
[TBL] [Abstract][Full Text] [Related]
15. Redistribution of transcription factor AP-2alpha in differentiating cultured human epidermal cells.
Mazina OM; Phillips MA; Williams T; Vines CA; Cherr GN; Rice RH
J Invest Dermatol; 2001 Oct; 117(4):864-70. PubMed ID: 11676824
[TBL] [Abstract][Full Text] [Related]
16. Activator protein-2α mediates carbon monoxide-induced stromal cell-derived factor-1α expression and vascularization in ischemic heart.
Lin HH; Chen YH; Chiang MT; Huang PL; Chau LY
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):785-94. PubMed ID: 23393395
[TBL] [Abstract][Full Text] [Related]
17. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells.
Nyormoi O; Wang Z; Doan D; Ruiz M; McConkey D; Bar-Eli M
Mol Cell Biol; 2001 Aug; 21(15):4856-67. PubMed ID: 11438643
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation.
Gille J; Swerlick RA; Caughman SW
EMBO J; 1997 Feb; 16(4):750-9. PubMed ID: 9049304
[TBL] [Abstract][Full Text] [Related]
20. Genomic structure and DNA binding properties of the human zinc finger transcriptional repressor AP-2rep (KLF12).
Roth C; Schuierer M; Günther K; Buettner R
Genomics; 2000 Feb; 63(3):384-90. PubMed ID: 10704285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
